THC Stock Forecast 2025-2026
Distance to THC Price Targets
THC Price Momentum
10 Quality Stocks Worth Considering Now
Researching Tenet Healthcare (THC) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on THC and similar high-potential opportunities.
Latest THC Stock Price Targets & Analyst Predictions
Based on our analysis of 34 Wall Street analysts, THC has a bullish consensus with a median price target of $175.00 (ranging from $134.00 to $217.00). The overall analyst rating is Strong Buy (8.8/10). Currently trading at $122.67, the median forecast implies a 42.7% upside. This outlook is supported by 17 Buy, 4 Hold, and 0 Sell ratings.
The most optimistic forecast comes from A.J. Rice at UBS, projecting a 76.9% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
THC Analyst Ratings
THC Price Target Range
Latest THC Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for THC.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Feb 13, 2025 | Barclays | Andrew Mok | Overweight | Maintains | $161.00 |
| Feb 13, 2025 | Cantor Fitzgerald | Sarah James | Overweight | Reiterates | $177.00 |
| Jan 7, 2025 | Keybanc | Tim Rezvan | Overweight | Maintains | $185.00 |
| Jan 6, 2025 | Truist Securities | David Macdonald | Buy | Maintains | $175.00 |
| Dec 17, 2024 | JP Morgan | Benjamin Rossi | Overweight | Assumes | $175.00 |
| Dec 16, 2024 | Goldman Sachs | Jamie Perse | Neutral | Downgrade | $140.00 |
| Nov 25, 2024 | Wells Fargo | Stephen Baxter | Equal-Weight | Downgrade | $150.00 |
| Nov 22, 2024 | Raymond James | John Ransom | Outperform | Downgrade | $195.00 |
| Nov 8, 2024 | Barclays | Andrew Mok | Overweight | Maintains | $190.00 |
| Nov 6, 2024 | Wells Fargo | Stephen Baxter | Overweight | Maintains | $205.00 |
| Oct 30, 2024 | Goldman Sachs | Jamie Perse | Buy | Maintains | $196.00 |
| Oct 30, 2024 | Truist Securities | David Macdonald | Buy | Reiterates | $190.00 |
| Oct 30, 2024 | UBS | A.J. Rice | Buy | Maintains | $217.00 |
| Oct 30, 2024 | Cantor Fitzgerald | Sarah James | Overweight | Maintains | $177.00 |
| Oct 30, 2024 | RBC Capital | Ben Hendrix | Outperform | Maintains | $183.00 |
| Oct 22, 2024 | Wells Fargo | Stephen Baxter | Overweight | Maintains | $195.00 |
| Oct 14, 2024 | Truist Securities | David Macdonald | Buy | Maintains | $180.00 |
| Oct 11, 2024 | Keybanc | Matthew Gillmor | Overweight | Initiates | $200.00 |
| Oct 4, 2024 | Cantor Fitzgerald | Sarah James | Overweight | Reiterates | $168.00 |
| Oct 1, 2024 | Cantor Fitzgerald | Sarah James | Overweight | Reiterates | $168.00 |
Tenet Healthcare Corporation (THC) Competitors
The following stocks are similar to Tenet Healthcare based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Tenet Healthcare Corporation (THC) Financial Data
Tenet Healthcare Corporation has a market capitalization of $11.67B with a P/E ratio of 3.8x. The company generates $20.66B in trailing twelve-month revenue with a 15.5% profit margin.
Revenue growth is -5.7% quarter-over-quarter, while maintaining an operating margin of +16.7% and return on equity of +57.8%.
Valuation Metrics
Growth & Margins
Financial Health
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Tenet Healthcare Corporation (THC) Business Model
About Tenet Healthcare Corporation
Provides diversified healthcare services across the U.S.
Tenet Healthcare Corporation operates a network of hospitals and health-related facilities, generating revenue through a variety of services including acute care, outpatient services, and specialty procedures. The company also enhances its financial performance through its subsidiary, Conifer Health Solutions, which offers value-based care and revenue cycle management services.
Founded in 1967 and headquartered in Dallas, Texas, Tenet is a significant player in the U.S. healthcare sector, focusing on optimizing patient outcomes and adapting to a regulatory-driven environment.
Company Information
Sector
Healthcare
Industry
Medical Care Facilities
Employees
74,480
CEO
Dr. Saumya Sutaria M.D.
Country
United States
IPO Year
1982
Website
www.tenethealth.comTenet Healthcare Corporation (THC) Latest News & Analysis
Tenet Healthcare (THC) Sees a More Significant Dip Than Broader Market: Some Facts to Know
3 days agoTenet Healthcare (THC) closed at $119.51, down 1.39% from the previous trading day.
Tenet Healthcare's decline of 1.39% signals potential volatility, affecting investor sentiment and may influence trading strategies and future performance assessments.
Tenet (THC) is gaining attention from Zacks.com users, indicating potential investor interest. Monitoring relevant facts is advised for assessing the stock's future prospects.
Increased attention from Zacks.com users may indicate heightened interest or potential volatility in Tenet's stock, impacting trading decisions and future price movements.
Zacks Style Scores help investors identify top-rated stocks aligned with their investing style, providing a straightforward method to enhance stock selection.
Zacks Style Scores can help investors identify high-potential stocks, enhancing portfolio performance through targeted investment strategies aligned with individual preferences.
Wall Street analyst recommendations impact stock prices and are commonly referenced by investors when deciding to Buy, Sell, or Hold stocks.
Wall Street analyst recommendations can significantly influence stock prices, impacting investor sentiment and trading decisions. Their ratings often serve as indicators of potential market movements.
THC is enhancing its focus on Ambulatory Surgical Centers (ASCs) to capitalize on the increasing demand for outpatient services.
THC's shift to outpatient services indicates potential revenue growth, aligning with market trends. This could enhance profitability and attract investor interest.
Zacks emphasizes its Rank system, focusing on earnings estimates and revisions to identify promising stocks, while also monitoring value, growth, and momentum trends.
Zacks' emphasis on earnings estimates and revisions signals potential stock performance, guiding investors toward high-quality picks based on value, growth, and momentum trends.
Frequently Asked Questions About THC Stock
What is Tenet Healthcare Corporation's (THC) stock forecast for 2025?
Based on our analysis of 34 Wall Street analysts, Tenet Healthcare Corporation (THC) has a median price target of $175.00. The highest price target is $217.00 and the lowest is $134.00.
Is THC stock a good investment in 2025?
According to current analyst ratings, THC has 17 Buy ratings, 4 Hold ratings, and 0 Sell ratings. The stock is currently trading at $122.67. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for THC stock?
Wall Street analysts predict THC stock could reach $175.00 in the next 12 months. This represents a 42.7% increase from the current price of $122.67. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Tenet Healthcare Corporation's business model?
Tenet Healthcare Corporation operates a network of hospitals and health-related facilities, generating revenue through a variety of services including acute care, outpatient services, and specialty procedures. The company also enhances its financial performance through its subsidiary, Conifer Health Solutions, which offers value-based care and revenue cycle management services.
What is the highest forecasted price for THC Tenet Healthcare Corporation?
The highest price target for THC is $217.00 from A.J. Rice at UBS, which represents a 76.9% increase from the current price of $122.67.
What is the lowest forecasted price for THC Tenet Healthcare Corporation?
The lowest price target for THC is $134.00 from at , which represents a 9.2% increase from the current price of $122.67.
What is the overall THC consensus from analysts for Tenet Healthcare Corporation?
The overall analyst consensus for THC is bullish. Out of 34 Wall Street analysts, 17 rate it as Buy, 4 as Hold, and 0 as Sell, with a median price target of $175.00.
How accurate are THC stock price projections?
Stock price projections, including those for Tenet Healthcare Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
